These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14413872)

  • 1. [Treatment of coronary insufficiency with 2, 6-bis(diethylamino)-4, 8-dipiperidino-pyrimido(5, 4-d)pyrimidine (persantin)].
    LANG O
    Wien Med Wochenschr; 1959 Dec; 109():1006-7. PubMed ID: 14413872
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental research on modifications of the coronary arteriographic picture induced by 2,6-bis(diethanolamino) 4,8,-dipiperidino-pyrimido(5,4-d) pyrimidine (Persantin)].
    AGATI G; NATTERO G; GULLINO D; FERRARA L; VIDILI F
    Minerva Cardioangiol; 1961 Nov; 9():701-5. PubMed ID: 13859565
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of coronary insufficiency with 2,6-bis(diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d)-pyrimidine].
    AGOTE POVEDA IP; VILLANUEVA EDO A; ALONSOLOMAS L; ARIAS MARTINEZ JL; SARRALDE G
    Rev Clin Esp; 1960 Dec; 79():181-9. PubMed ID: 13681671
    [No Abstract]   [Full Text] [Related]  

  • 4. [The action of the pyrimido-pyrimidine derivative in the treatment of coronary insufficiency].
    BRIQUEMONT F
    Brux Med; 1962 Feb; 42():241-52. PubMed ID: 13873145
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of coronary insufficiency with Persantin].
    RIEGLER E
    Wien Z Inn Med; 1961 Mar; 42():140-2. PubMed ID: 13741533
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental and clinical observations on 2,6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d) pyrimidine (Persantin).
    SOLOFF LA; GIMENEZ JL; WINTERS WL
    Am J Med Sci; 1962 Jun; 243():783-9. PubMed ID: 13914979
    [No Abstract]   [Full Text] [Related]  

  • 7. [TREATMENT OF CORONARY INSUFFICIENCY WITH 2,6-BIS-DIETHANOLAMINO-4,8-DIPIPERIDINO-PYRIMIDO(5,4-D)PYRIMIDINE].
    DEVEYT F
    Belg Tijdschr Geneesk; 1964 Feb; 20():181-4. PubMed ID: 14139392
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical trials with persantin in the therapy of coronary and myocardial insufficiency].
    ROESELER E
    Med Welt; 1960 Nov; 48():2562-4. PubMed ID: 13742702
    [No Abstract]   [Full Text] [Related]  

  • 9. [The use of a pyrimido-pyrimidine derivative as coronary vasodilator in clinical practice].
    BENITO SENDIN M; ALVAREZ SANCHEZ E
    Medicina (Madr); 1961 Oct; 29():469-82. PubMed ID: 13867248
    [No Abstract]   [Full Text] [Related]  

  • 10. Observations on the coronary vasodilator effect of 'persantin'.
    PEEL AA; BLUM K; LANCASTER WM; DALL JL; CHALMERS GL
    Scott Med J; 1961 Sep; 6():403-10. PubMed ID: 13733892
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies with a new coronary vasodilator drug: persantin.
    KINSELLA D; TROUP W; McGREGOR M
    Am Heart J; 1962 Feb; 63():146-51. PubMed ID: 14456202
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical and experimental studies on persantin in coronary diseases].
    GREIF S
    Wien Med Wochenschr; 1960 Jun; 110():463-6. PubMed ID: 13851721
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical results with a new coronary dilatator agent: persantin].
    MARTINEZ RAMON E; ALCALA LLORENTE E
    Med Esp; 1961 Jun; 45():470-87. PubMed ID: 13767501
    [No Abstract]   [Full Text] [Related]  

  • 14. [On heart therapy with Persantin].
    WOLF H
    Wien Med Wochenschr; 1961 May; 111():357-61. PubMed ID: 13786276
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contribution to the study of a pyrimido-pyrimidine derivative].
    LOPEZ MERINO V; ALGARRA GONZALEZ F; PONS ESPANA E
    Med Esp; 1961 Sep; 46():204-13. PubMed ID: 14466606
    [No Abstract]   [Full Text] [Related]  

  • 16. [Persantin in arteriosclerotic cardiac disease. Study of 30 patients].
    RODRIGUEZ ALVAREZ J
    Med Esp; 1961 Mar; 45():235-41. PubMed ID: 13742567
    [No Abstract]   [Full Text] [Related]  

  • 17. [INFLUENCING OF CARBON MONOXIDE POISONING IN MICE BY 2,6-BIS-(DIETHAMOLAMINO)-4,8-DIPIPERIDINO-PYRIMIDO-(5,4-D)-PYRIMIDINE (PERSANTIN)].
    FRIMMER M; HEGNER D
    Klin Wochenschr; 1963 Dec; 41():1165-6. PubMed ID: 14118126
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinico-experimental observations on a new coronaro-dilator drug, pyrimido-pyrimidine cyclic derivative].
    GRIMALDI F; ZINNARI A; GASTALDI E
    Riforma Med; 1961 Dec; 75():1397-402. PubMed ID: 13901941
    [No Abstract]   [Full Text] [Related]  

  • 19. Potentiation of the coronary vasodilator effect of norepinephrine by 2,6-bis (diethanolamino)-4,8-dipiperidino-pyrimido (5,4-d) pyrimidine (dipyridamole).
    Hashimoto K; Sano N
    Tohoku J Exp Med; 1968 Oct; 96(2):207-8. PubMed ID: 5708523
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on the effect of 2,6-bis(dethanolamino)-4, 8-dipiperidino-pyrimido(5,4-d) pyrimidine on myocardial metabolism].
    KUNZ W; SCHMID W; SIESS M
    Arzneimittelforschung; 1962 Nov; 12():1098-109. PubMed ID: 13927401
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.